Novel Ebola Vaccine Provides Sustained Antibody Response One Year After Administration
June 22nd 2017The results of a recent Phase IB study show that the novel Ebola vaccine, V920, was well-tolerated and “stimulated a rapid onset of binding and neutralizing antibodies,” which persisted for up to 1 year.
West Nile Virus Hits Biggest Urban Areas of the US
June 21st 2017Health officials in New York City are seeing the first West Nile virus-positive mosquitoes of the season as Los Angeles County reports its first human case of the year, marking new West Nile activity in the country’s biggest urban areas.
Market Pressures Hinder Access to Essential Antibiotics
June 20th 2017Commentary authors warn that lack of access to antibiotics to treat common bacterial infections are becoming difficult to access due to manufacturers finding them less profitable to produce and market; this can have serious implications.
Fighting Meningococcal Disease in the "Meningitis Belt"
June 19th 2017The CDC examines the high incidence of meningococcal disease in the “meningitis belt,” found within sub-Saharan Africa, and the efforts of the Meningitis Vaccine Project to monitor the impact of a meningococcal A conjugate vaccine.
Will Pennsylvania Proposal Sanction Improper Treatment of Lyme Disease?
June 16th 2017Amesh A. Adalja, MD, FIDSA argues that a bill being considered in the Pennsylvania state legislature will ultimately result in increased antibiotic resistance and will set back the clock for finding appropriate treatments for Lyme disease.